3rd generation glp-1 There's a new name in the GLP conversation — and it's worth paying attention to. Retatrutide is a triple-agonist therapy that targets GLP-1, GIP, and glucagon receptors simultaneously. In clinical trials, it What is the Difference Between

DSIP research extends beyond sleep physiology into areas including opioid receptor modulation, withdrawal symptom attenuation, and free radical scavenging activity

T.BaerD

Four percent of Parkinsons patients are diagnosed before age 50

To meet the diagnostic criteria for cEDS, a person must meet: Major criterion 1 AND major criterion 2 OR Major criterion 1 AND three or more minor criteria Major Criteria Skin hyperextensibility and atrophic scarring Generalized joint hypermobility Minor Criteria Easy bruising Soft, doughy skin Skin fragility (or traumatic splitting) Molluscoid pseudotumors Subcutaneous spheroids Hernia (or history thereof) Epicanthal folds Complications of joint hypermobility (e.g., sprains, dislocations/subluxations, pain, flexible flatfoot) Family history of a first-degree relative who meets clinical criteria Genetic testing is used to see if a person has a genetic variant that causes vEDS

It is the shortest synthetic GHRH fragment that retains full biological activity at the GHRH receptor